Blood marker may foretell COVID-19 survival
NCT ID NCT05413824
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 28 times
Summary
This study looked at whether a blood test marker called NEU-SFL, which reflects immune cell activity, can help predict the risk of death in people hospitalized with COVID-19 in 2021. Researchers compared NEU-SFL levels between those who survived and those who did not. The goal was to see if this marker could be used as a tool to identify high-risk patients early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Nimes
Nîmes, 30029, France
Conditions
Explore the condition pages connected to this study.